OmniAb (OABI) Change in Cash (2021 - 2026)
OmniAb (OABI) reported Change in Cash of $3.5 million for Q1 2026, up 121.08% year-over-year from $1.6 million in Q1 2025, and up 216.89% quarter-over-quarter from -$3.0 million in Q4 2025.
OmniAb (OABI) Change in Cash (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Change in Cash data on file, last reported at $3.5 million in Q1 2026.
- Change in Cash for Q1 2026 came in at $3.5 million, up 121.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.2 million (up 322.26% YoY), and the FY2025 annual result was -$2.1 million, down 118.45% from the prior year.
- Change in Cash grew to $3.5 million in Q1 2026 per OABI's latest filing, from -$3.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $33.8 million in Q4 2022 and troughed at -$16.7 million in Q1 2025.
- A 5-year average of $2.1 million and a median of $1.0 million in 2024 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash soared 9442.55% in 2022, then plunged 932.32% in 2025.
- A 5-year view of Change in Cash shows it stood at $33.8 million in 2022, then slumped by 114.44% to -$4.9 million in 2023, then jumped by 107.41% to $362000.0 in 2024, then sank by 932.32% to -$3.0 million in 2025, then surged by 216.89% to $3.5 million in 2026.
- Business Quant data shows OABI's Change in Cash at $3.5 million in Q1 2026, -$3.0 million in Q4 2025, and $10.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | 3.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.52 Mn |
| Dec 31, 2025 | -3.01 Mn |
| Sep 30, 2025 | 10.26 Mn |
| Jun 30, 2025 | 7.39 Mn |
| Mar 31, 2025 | -16.71 Mn |
| Dec 31, 2024 | 362,000.00 |
| Sep 30, 2024 | 6.44 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 2.70 Mn |
| Dec 31, 2023 | -4.89 Mn |
| Sep 30, 2023 | 259,000.00 |
| Jun 30, 2023 | -1.76 Mn |
| Mar 31, 2023 | -10.53 Mn |
| Dec 31, 2022 | 33.84 Mn |
| Dec 31, 2021 | -362,203.00 |
| Sep 30, 2021 | 326,058.00 |